Learn More
Meridian Bioscience™ Alethia™ Bordetella Pertussis Kit
Description
Bordetella Pertussis is the pathogen responsible for the endemic respiratory disease whooping cough. Although there is a vaccine available, it is currently showing an increase of reportable infections in the US. Molecular assays are increasingly being used due to improved sensitivity and rapid turnaround time.
- Based on loop-mediated isothermal DNA amplification (LAMP) technology
- Result interpretation in less than 1 hour by illumipro-10 Incubator/Reader
- High sensitivity (87.8%) and specificity (97.8%)
- Quicker initiation of patient treatment
- Small instrument footprint
- Simple testing protocol, easily train all laboratory personnel
The device is not intended for point-of-care use.
Healthcare industry
This product(s) resides on a Fisher Scientific GSA or VA contract. If you are viewing this page as a nonregistered user, the price(s) displayed is List Price. To view your GSA or VA contract pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. You can also view your contract price by searching for this item(s) on GSA Advantage. To place an order, contact Fisher Scientific Customer Service.
Specifications
Specifications
| Content And Storage | 2°C to 30°C |
| For Use With (Application) | Detection of Bordetella pertussis in nasopharyngeal swab samples |
| Quantity | 50 Tests |
| Sensitivity Drift | 87.8% |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.